The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice

被引:22
作者
Cox, Rebecca Jane [1 ]
Hovden, Arnt-Ove
Brokstad, Karl Albert
Szyszko, Ewa
Madhun, Abdullah Sami
Haaheim, Lars Reinhardt
机构
[1] Univ Bergen, Gade Inst, Influenza Ctr, N-5021 Bergen, Norway
[2] Univ Bergen, Gade Inst, Broegelmann Res Lab, N-5021 Bergen, Norway
[3] Haukeland Hosp, Dept Otorhinolaryngol Head & Neck Surg, N-5021 Bergen, Norway
[4] Univ Bergen, Dept Surg Sci, Sect Otorhinolaryngol & Head & Neck Surg, Bergen, Norway
关键词
influenza vaccine; mouse; whole virus vaccine; split virus vaccine; immune response;
D O I
10.1016/j.vaccine.2006.05.040
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recently the urgency of developing a pandemic influenza vaccine has lead to the re-evaluation of the use of whole virus vaccine. We have compared the humoral immune response and the protective efficacy of whole and split influenza virus vaccines in mice. Whole virus vaccine was more immunogenic particularly after the first dose of vaccine, generally eliciting higher numbers of systemic antibody secreting cells and an earlier and higher neutralising antibody response. Immunisation with one dose of whole virus vaccine more effectively reduced viral shedding upon non-lethal homologous viral challenge, but two doses of split virus vaccine was most effective at limiting viral replication and this was correlated with high influenza specific serum IgG concentrations. The two vaccine formulations induced different T helper profiles particularly after one dose of vaccine; split virus vaccine induced a type 2 bias response, whereas whole virus vaccine elicited a dominant type I response. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6585 / 6587
页数:3
相关论文
共 21 条
[1]  
[Anonymous], TXB INFLUENZA
[2]   Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes [J].
Arkema, A ;
Huckriede, A ;
Schoen, P ;
Wilschut, J ;
Daemen, T .
VACCINE, 2000, 18 (14) :1327-1333
[3]   Virosome-mediated delivery of protein antigens to dendritic cells [J].
Bungener, L ;
Serre, K ;
Bijl, L ;
Leserman, L ;
Wilschut, J ;
Daemen, T ;
Machy, P .
VACCINE, 2002, 20 (17-18) :2287-2295
[4]   Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use [J].
Hehme, N ;
Engelmann, H ;
Kuenzel, W ;
Neumeier, E ;
Saenger, R .
VIRUS RESEARCH, 2004, 103 (1-2) :163-171
[5]   Pandemic preparedness:: lessons learnt from H2N2 and H9N2 candidate vaccines [J].
Hehme, N ;
Engelmann, H ;
Künzel, W ;
Neumeier, E ;
Sänger, R .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2002, 191 (3-4) :203-208
[6]   Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice [J].
Hovden, AO ;
Cox, RJ ;
Haaheim, LR .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2005, 62 (01) :36-44
[7]   Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice [J].
Hovden, AO ;
Cox, RJ ;
Madhun, A ;
Haaheim, LR .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2005, 62 (04) :342-352
[8]   Immunization against influenza: Comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults [J].
Keitel, WA ;
Cate, TR ;
Nino, D ;
Huggins, LL ;
Six, HR ;
Quarles, JM ;
Couch, RB .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (02) :329-332
[9]   HIGH-DOSES OF PURIFIED INFLUENZA-A VIRUS HEMAGGLUTININ SIGNIFICANTLY AUGMENT SERUM AND NASAL SECRETION ANTIBODY-RESPONSES IN HEALTHY-YOUNG ADULTS [J].
KEITEL, WA ;
COUCH, RB ;
CATE, TR ;
HESS, KR ;
BAXTER, B ;
QUARLES, JM ;
ATMAR, RL ;
SIX, HR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) :2468-2473
[10]   Direct cross-priming by Th lymphocytes generates memory cytotoxic T cell responses [J].
Kennedy, R ;
Undale, AH ;
Kieper, WC ;
Block, MS ;
Pease, LR ;
Celis, E .
JOURNAL OF IMMUNOLOGY, 2005, 174 (07) :3967-3977